JPMorgan Chase & Co’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-229,456
| Closed | -$17.3M | – | 6113 |
|
|
2022
Q2 | $17.3M | Sell |
229,456
-154,970
| -40% | -$11.7M | ﹤0.01% | 1522 |
|
|
2022
Q1 | $10.3M | Buy |
384,426
+65,212
| +20% | +$1.75M | ﹤0.01% | 2011 |
|
|
2021
Q4 | $15.2M | Buy |
319,214
+52,083
| +19% | +$2.48M | ﹤0.01% | 1779 |
|
|
2021
Q3 | $17.7M | Sell |
267,131
-16,586
| -6% | -$1.1M | ﹤0.01% | 1644 |
|
|
2021
Q2 | $22.1M | Buy |
283,717
+252,994
| +823% | +$19.7M | ﹤0.01% | 1555 |
|
|
2021
Q1 | $2.91M | Sell |
30,723
-16,996
| -36% | -$1.61M | ﹤0.01% | 3003 |
|
|
2020
Q4 | $5.82M | Buy |
47,719
+16,318
| +52% | +$1.99M | ﹤0.01% | 2316 |
|
|
2020
Q3 | $2.78M | Buy |
31,401
+11,216
| +56% | +$993K | ﹤0.01% | 2580 |
|
|
2020
Q2 | $1.3M | Sell |
20,185
-12,933
| -39% | -$836K | ﹤0.01% | 2890 |
|
|
2020
Q1 | $1.48M | Buy |
33,118
+11,910
| +56% | +$532K | ﹤0.01% | 2752 |
|
|
2019
Q4 | $1.32M | Buy |
21,208
+19,031
| +874% | +$1.19M | ﹤0.01% | 2908 |
|
|
2019
Q3 | $82K | Buy |
2,177
+353
| +19% | +$13.3K | ﹤0.01% | 4064 |
|
|
2019
Q2 | $71K | Buy |
+1,824
| New | +$71K | ﹤0.01% | 4134 |
|